thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

COVID Vaccines

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By NewsFacts Bureau

COVAXIN production to be demand-driven, says Bharat Biotech

By TheNewsFacts

iNCOVACC: Bharat Biotech Reveals World’s 1st Nasal COVID Vaccine Price

By TheNewsFacts

Bharat Biotech iNCOVACC Vaccine priced ₹800 in CoWIN, ₹325 for the Govt Supplies, Rollout in January 2023

By TheNewsFacts
Jemimah Rodrigues

CWC25: Gavaskar Ready to Jam with Jemimah Rodrigues if India Wins

By NewsFacts Bureau
October 31, 2025
The Rage of Kaantha

The Rage of Kaantha’ is the New Rap Anthem of India

By NewsFacts Bureau
October 30, 2025
Deepika Padukone Kalki

Kalki 2898 AD: From Spotlight to Shadows, Deepika’s Vanishing Act

By NewsFacts Bureau
October 29, 2025
Kantara Chapter 1

Kantara Chapter 1 Hits ₹590 Crore as OTT Launch Nears

By NewsFacts Bureau
October 27, 2025

Latest Articles

Moderna sues Pfizer and BioNTech for violating the Covid19 vaccine patent

Moderna sues Pfizer and BioNTech for violating the Covid19 vaccine patent

By TheNewsFacts
Intranasal Covid vaccine BBV154 is safe, regulators approvals awaited: Bharat Biotech

Intranasal Covid vaccine BBV154 is safe, regulators approvals awaited: Bharat Biotech

By TheNewsFacts
Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

By TheNewsFacts
New Peer Review Proves COVAXIN Booster Dose Provides Multiple Benefits

New Peer Review Proves COVAXIN Booster Dose Provides Multiple Benefits

By TheNewsFacts
COVAXIN Latest Peer Review Shows robust safety, immunogenicity in 2-18 years Old

COVAXIN is Safe, Highly Immunogenic in 2-18 Years Old – The Lancet Review

By TheNewsFacts
Covaxin booster can defend new variants of concern: ICMR Study

COVAXIN booster can defend new variants of concern: ICMR Study

By TheNewsFacts
Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

By TheNewsFacts
India Approves COVAXIN for Children 6 to 12 Years Age

India Approves COVAXIN for Children 6 to 12 Years Age

By TheNewsFacts
1 2 3 4 … 8 9
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?